AGP Picks
View all

Simvera launches software to model patient support staffing decisions

Sep. 15, 2026
By AI, Created 13:15 UTC, Sep 15, 2026, AGP -

Simvera has launched Simvera PSP, a platform for pharmaceutical and biotech manufacturers to simulate patient support program staffing, vendor, and design choices before committing budget. The software uses queueing science to forecast cost, service levels, and patient experience as hubs face growing pressure to staff efficiently.

Why it matters: - Pharmaceutical patient support hubs often rely on simple staffing ratios that can leave capacity idle or patients waiting. - Simvera PSP is designed to help leaders test staffing and program design choices before they spend money or sign contracts. - The platform aims to reduce operational risk in patient services, market access, commercial operations, and procurement decisions.

What happened: - Simvera, Inc. announced the launch of Simvera PSP, a patient support program staffing and optimization platform for pharmaceutical and biotech manufacturers. - The launch gives directors and senior managers a tool to model the outcome of a design decision before committing budget. - The company said the software is available now. - Manufacturers, vendors, and pharmacy partners can request a demo at more information.

The details: - Simvera PSP uses peer-reviewed queueing science, the same type of math used to optimize call centers and emergency departments. - The platform simulates real patient flow and case volume in a patient support program. - Users can stress-test scenarios including an indication expansion, a launch ramp, a vendor transition, or a shift in call mix. - Each scenario returns the impact on cost, service level, and patient experience. - The software is patent-pending. - The product is built to answer questions about agent staffing levels, role mix, vendor transition capacity, budget constraints, and RFP comparisons. - Simvera says the tool helps teams compare competing vendor proposals during procurement.

Between the lines: - Vendor transitions are accelerating across the pharmaceutical industry, raising the stakes for capacity and cost planning before go-live. - The launch reflects a broader push to replace intuition-based hub planning with more defensible operational modeling. - Douglas Bock, founder and CEO of Simvera, said the gap in effective patient support hub staffing has been tools, not talent. - Bock said the industry has long lacked a reliable way to test how staffing choices and program changes may affect patients in advance.

What's next: - Simvera plans to extend the platform across the broader commercial lifecycle in the coming months. - The company is positioning Simvera PSP for teams that run hubs day to day as well as leaders in commercial, market access, and procurement. - Simvera said the platform is intended to help manufacturers hold service levels while keeping costs defensible.

The bottom line: - Simvera is betting manufacturers will pay for better forecasting when patient support programs become harder to staff and more expensive to mismanage.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.